Stockreport

Lilly vs Novo Nordisk. Why 2026 Could Redefine the Obesity Drug Market [Yahoo! Finance]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF Novo Nordisk and Eli Lilly lead the wave. Novo's oral semaglutide may win approval this year and reach patients early next year. Lilly's orforglipron aims for approval [Read more]